Click on the ticker for details on a company

Recent Activity in the Marketplace

  • WuXi AppTec Will Acquire ResearchPoint Global

    October 19, 2017 — WuXi AppTec, China’s largest CRO/CMO, will acquire clinical-stage contract research company, ResearchPoint Global, of Austin, Texas. Founded in 1999, RPG has 450 employees in 60 countries. The company offers a range of clinical CRO services to small and medium-sized pharmas. Financial details were not disclosed.

  • Quest Diagnostics Inc. Acquires Cleveland HeartLab

    October 18, 2017 — Quest Diagnostics Inc. announced it will acquire Cleveland HeartLab, a purveyor of diagnostic services for managing cardiovascular disease, from equity investors. Quest intends to establish a national center of excellence in diagnostic information services at Cleveland HeartLab’s specialized laboratory in Cleveland, Ohio, focused on services that aid in assessing risk and treatment protocols for heart disease.

  • Brooks Automation Buys 4titude, Ltd. for $65M

    October 05, 2017 — Brooks Automation, Inc. has acquired 4titude, Ltd., a manufacturer of scientific consumables for biological sample materials used in a variety of genomic and DNA analytical applications. Based in Surrey, England, 4titude provides consumable PCR plates which are used to amplify small segments of DNA, as well as a range of sealing and sequencing tubes related to bench top instrumentation. They have over 1200 global customers in the pharma, biotech, academic, and biobanking markets.

  • Precision For Medicine Acquires Epiontis

    October 4, 2017 — Precision for Medicine, part of the Precision Medicine Group, has acquired Berlin-based Epiontis GmbH, a next-generation European specialty laboratory providing immune monitoring services through an epigenetic platform. The acquisition adds Epiontis’s epigenetic technology and expertise to Precision’s suite of immune monitoring services for clinical trials.

  • Bruker Acquires Merlin Diagnostika GmbH

    September 26, 2017 — Bruker announced the acquisition of Merlin Diagnostika GmbH, located near Bonn, Germany. Merlin provides products, services and consulting in the fields of antibiotic resistance testing and antibiotic susceptibility testing. MERLIN’s technology and product portfolio for human and veterinary antibiotic resistance and specialty susceptibility testing will enable Bruker to add these tests to its MALDI Biotyper® Microbial Identification Platform. Merlin will become Bruker´s Center of Excellence for specialty biochemical and selected, high-value MALDI Biotyper-based antibiotic resistance and susceptibility testing.

  • Archive of Activity in the Marketplace